BNTX: BioNTech SE - American Depositary Shares
今日BNTX汇率已更改0.04%。当日,交易品种以低点91.02和高点92.35进行交易。
关注BioNTech SE - American Depositary Shares动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BNTX新闻
- Moderna's Respiratory Portfolio Expands: Can It Reduce COVID Reliance?
- Pfizer's Non-Oncology Performance in Q3: Driving Factors to Watch
- BioNTech To Present New Clinical Data From Its Late-Stage Oncology Pipeline With 16 Abstracts At European Society For Medical Oncology, October 23–27; Key Oral Presentations Will Focus On Clinical Data For Pumitamig Plus Docetaxel In Second-Line...
- Canaccord Genuity Maintains Buy on BioNTech, Lowers Price Target to $132
- Why Is BioNTech Stock Falling Tuesday?
- BioNTech 股票为什么在周二下跌?
- MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?
- Syndax Pharmaceuticals, BioNTech, Seagate And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
- Syndax制药、BioNTech、西部数据及其他大盘股在周二盘前交易中走低
- BioNTech Reports AHEAD-MERIT Phase 2/3 Clinical Trial Did Not Meet First Dual Primary Endpoint Of Progression-Free Survival For mRNA Cancer Immunotherapy Candidate BNT113 Plus Pembrolizumab Compared With Pembrolizumab Alone
- Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines
- 癌症新战役?NIH疫苗计划引发生物科技股上涨
- A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
- Reported Earlier: 'Cancer Vaccines Are the N.I.H's Next Big Bet' - The New York Times
- 更早报道:《癌症疫苗是美国国立卫生研究院的下一个重大赌注》——《纽约时报》
- 摩根士丹利维持对BioNTech的增持评级,将目标价下调至114美元
- Morgan Stanley Maintains Overweight on BioNTech, Lowers Price Target to $114
- BioNTech SE: Moving Past Covid (NASDAQ:BNTX)
- Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz
- Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now?
- Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody
- AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck
- Wall Street Breakfast Podcast: Federal Boost For Navitas
- BioNTech因未能找到买家而计划关闭德国三家工厂-路透社报道
常见问题解答
BNTX股票今天的价格是多少?
BioNTech SE - American Depositary Shares股票今天的定价为91.21。它在91.02 - 92.35范围内交易,昨天的收盘价为91.17,交易量达到2564。BNTX的实时价格图表显示了这些更新。
BioNTech SE - American Depositary Shares股票是否支付股息?
BioNTech SE - American Depositary Shares目前的价值为91.21。股息政策取决于公司,而投资者也会关注-13.04%和USD。实时查看图表以跟踪BNTX走势。
如何购买BNTX股票?
您可以以91.21的当前价格购买BioNTech SE - American Depositary Shares股票。订单通常设置在91.21或91.51附近,而2564和-0.04%显示市场活动。立即关注BNTX的实时图表更新。
如何投资BNTX股票?
投资BioNTech SE - American Depositary Shares需要考虑年度范围79.52 - 123.98和当前价格91.21。许多人在以91.21或91.51下订单之前,会比较-6.54%和。实时查看BNTX价格图表,了解每日变化。
BioNTech SE - American Depositary Shares股票的最高价格是多少?
在过去一年中,BioNTech SE - American Depositary Shares的最高价格是123.98。在79.52 - 123.98内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪BioNTech SE - American Depositary Shares的绩效。
BioNTech SE - American Depositary Shares股票的最低价格是多少?
BioNTech SE - American Depositary Shares(BNTX)的最低价格为79.52。将其与当前的91.21和79.52 - 123.98进行比较,可以发现潜在的长期切入点。观看BNTX在图表上的实时走势以获取更多详细信息。
BNTX股票是什么时候拆分的?
BioNTech SE - American Depositary Shares历史上曾经历过股票拆分。这些变化在公司行动后的、91.17和-13.04%中可见。
- 前一天收盘价
- 91.17
- 开盘价
- 91.25
- 卖价
- 91.21
- 买价
- 91.51
- 最低价
- 91.02
- 最高价
- 92.35
- 交易量
- 2.564 K
- 日变化
- 0.04%
- 月变化
- -6.54%
- 6个月变化
- -7.38%
- 年变化
- -13.04%
- 实际值
- -3.060 M
- 预测值
- -4.804 M
- 前值
- -8.557 M
- 实际值
- 0.987 M
- 预测值
- -0.153 M
- 前值
- 1.862 M
- 实际值
- 预测值
- 前值
- 5.420%